SK pharmteco
Honggeun Park is currently the Associate Director of Molecular Biology, Testing and Analytic Services at SK pharmteco, where responsibilities include leading a molecular testing group for GMP release and oversighting assay development. Previously, Honggeun served as Principal Scientist in Analytical Development at the Center for Breakthrough Medicines, focusing on method development for viral vector products and developing various molecular and immunoassays. Additional experience includes roles as Senior Research Scientist at SwanBio Therapeutics, Associate Research Scientist and Postdoctoral Research Scientist at Columbia University Irving Medical Center, and Postdoctoral Fellow at Burke Neurological Institute and Seoul National University. Educational qualifications include a Ph.D. in Biological and Biomedical Sciences from Seoul National University.
This person is not in any teams
This person is not in any offices
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.